Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$390K Buy
+3,300
New +$381K ﹤0.01% 3624
2025
Q2
Sell
-119,100
Closed -$14.2M 5154
2025
Q1
$14.2M Buy
+119,100
New +$14.8M 0.02% 858
2024
Q2
Sell
-85,700
Closed -$11.1M 4730
2024
Q1
$11.1M Sell
85,700
-134,200
-61% -$16.2M 0.02% 934
2023
Q4
$25.1M Buy
219,900
+184,900
+528% +$18.5M 0.05% 461
2023
Q3
$3.19M Buy
+35,000
New +$3.61M 0.01% 1476

Other funds holding XYL

Squarepoint's XYL Position: Q2 2026 in Review

Squarepoint reduced its Xylem (XYL) stake by 56% in Q2 2026, selling an estimated $8.1M and leaving 55,313 shares worth $6.54M. The position accounts for 0.01% of the portfolio, ranked #1378.

Squarepoint first reported a position in XYL in Q4 2015 and has held it in 31 quarters since. The position peaked at $51.8M in Q2 2023. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Squarepoint held 55,313 shares of Xylem worth $6.54M as of Q2 2026.
  • Squarepoint sold 70,140 Xylem shares in Q2 2026, an estimated $8.1M.
  • Xylem made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1378 holding.
  • Squarepoint first reported a position in Xylem in Q4 2015 and has held it in 31 quarters since.
  • Squarepoint's Xylem position peaked at $51.8M in Q2 2023.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.